12/17
08:15 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $42.00 price target on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $42.00 price target on the stock.
12/16
10:11 am
hims
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
Low
Report
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
12/16
09:17 am
hims
HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further? [Yahoo! Finance]
Medium
Report
HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further? [Yahoo! Finance]
12/12
09:00 am
hims
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
Low
Report
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
12/3
01:08 pm
hims
Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category [Yahoo! Finance]
Low
Report
Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category [Yahoo! Finance]
12/3
12:58 pm
hims
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
Low
Report
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
12/3
11:04 am
hims
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know [Yahoo! Finance]
Low
Report
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know [Yahoo! Finance]
12/2
09:38 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $28.00 to $38.00. They now have a "buy" rating on the stock.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $28.00 to $38.00. They now have a "buy" rating on the stock.
11/29
10:00 am
hims
Teladoc Stock Rises 59.4% in Three Months: Is This Your Buy Signal? [Yahoo! Finance]
Medium
Report
Teladoc Stock Rises 59.4% in Three Months: Is This Your Buy Signal? [Yahoo! Finance]
11/25
06:34 pm
hims
Bitcoin breaks from rally, CHIPS Act future: Market Domination [Yahoo! Finance]
Low
Report
Bitcoin breaks from rally, CHIPS Act future: Market Domination [Yahoo! Finance]
11/25
06:34 pm
hims
Bitcoin breaks from rally, CHIPS Act future: Market Domination [Yahoo! Finance Canada]
Low
Report
Bitcoin breaks from rally, CHIPS Act future: Market Domination [Yahoo! Finance Canada]
11/22
08:59 am
hims
What's Happening With HIMS Stock? [Forbes]
Medium
Report
What's Happening With HIMS Stock? [Forbes]
11/21
12:10 pm
hims
Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys [Yahoo! Finance]
Medium
Report
Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys [Yahoo! Finance]
11/21
12:00 pm
hims
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
Medium
Report
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
11/20
01:16 pm
hims
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead [Seeking Alpha]
Low
Report
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead [Seeking Alpha]
11/20
10:48 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at TD Cowen. They now have a $28.00 price target on the stock.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at TD Cowen. They now have a $28.00 price target on the stock.
11/18
06:10 am
hims
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions [Yahoo! Finance]
Medium
Report
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions [Yahoo! Finance]
11/18
06:00 am
hims
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Medium
Report
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
11/17
04:59 pm
hims
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory [Yahoo! Finance]
11/14
01:31 pm
hims
Hims & Hers Health, Inc. (NYSE: HIMS) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.
11/14
10:29 am
hims
Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15% [CNBC]
High
Report
Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15% [CNBC]
11/13
01:51 pm
hims
What's Going On With Hims & Hers Health Stock On Wednesday? [Yahoo! Finance]
Low
Report
What's Going On With Hims & Hers Health Stock On Wednesday? [Yahoo! Finance]
11/13
09:15 am
hims
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
Medium
Report
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
11/12
07:02 am
hims
Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality [Yahoo! Finance]
Low
Report
Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality [Yahoo! Finance]
11/8
01:50 pm
hims
Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy? [Yahoo! Finance]
Low
Report
Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy? [Yahoo! Finance]